134 related articles for article (PubMed ID: 27185377)
21. Combined normal donor and CLL: Single tube ZAP-70 analysis.
Degheidy HA; Venzon DJ; Farooqui MZ; Abbasi F; Arthur DC; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2012 Mar; 82(2):67-77. PubMed ID: 22031337
[TBL] [Abstract][Full Text] [Related]
22. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia.
Strati P; Parikh SA; Chaffee KG; Achenbach SJ; Slager SL; Call TG; Ding W; Jelinek DF; Hanson CA; Kay NE; Shanafelt TD
Br J Haematol; 2017 Jul; 178(1):99-105. PubMed ID: 28386906
[TBL] [Abstract][Full Text] [Related]
23. Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.
Kaplan D; Sun Z; Tallman MS; Flinn IW; Xiao W; Caimi PF; Kaye NM; Lazarus HM
Cytometry A; 2014 Sep; 85(9):798-808. PubMed ID: 24845539
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
Nadeu F; Clot G; Delgado J; Martín-García D; Baumann T; Salaverria I; Beà S; Pinyol M; Jares P; Navarro A; Suárez-Cisneros H; Aymerich M; Rozman M; Villamor N; Colomer D; González M; Alcoceba M; Terol MJ; Navarro B; Colado E; Payer ÁR; Puente XS; López-Otín C; López-Guillermo A; Enjuanes A; Campo E
Leukemia; 2018 Mar; 32(3):645-653. PubMed ID: 28924241
[TBL] [Abstract][Full Text] [Related]
25. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
Rossi D; Rasi S; Fabbri G; Spina V; Fangazio M; Forconi F; Marasca R; Laurenti L; Bruscaggin A; Cerri M; Monti S; Cresta S; Famà R; De Paoli L; Bulian P; Gattei V; Guarini A; Deaglio S; Capello D; Rabadan R; Pasqualucci L; Dalla-Favera R; Foà R; Gaidano G
Blood; 2012 Jan; 119(2):521-9. PubMed ID: 22077063
[TBL] [Abstract][Full Text] [Related]
26. Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation.
Degheidy HA; Venzon DJ; Farooqui MZ; Abbasi F; Arthur DC; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2011 Sep; 80(5):309-17. PubMed ID: 21472850
[TBL] [Abstract][Full Text] [Related]
27. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M; Hartmann E; Kipps TJ; Rassenti L; Krupnik D; Lerner S; LaPushin R; Xiao L; Huang X; Werner L; Neuberg D; Kantarjian H; O'Brien S; Wierda WG; Keating MJ; Rosenwald A; Burger JA
Blood; 2011 Feb; 117(5):1662-9. PubMed ID: 21115978
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
29. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.
Zent CS; Kay NE
Leuk Lymphoma; 2011 Aug; 52(8):1425-34. PubMed ID: 21649549
[TBL] [Abstract][Full Text] [Related]
30. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
31. B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia.
Vangapandu HV; Havranek O; Ayres ML; Kaipparettu BA; Balakrishnan K; Wierda WG; Keating MJ; Davis RE; Stellrecht CM; Gandhi V
Mol Cancer Res; 2017 Dec; 15(12):1692-1703. PubMed ID: 28835371
[TBL] [Abstract][Full Text] [Related]
32. Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract][Full Text] [Related]
33. Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Knisbacher BA; Lin Z; Hahn CK; Nadeu F; Duran-Ferrer M; Stevenson KE; Tausch E; Delgado J; Barbera-Mourelle A; Taylor-Weiner A; Bousquets-Muñoz P; Diaz-Navarro A; Dunford A; Anand S; Kretzmer H; Gutierrez-Abril J; López-Tamargo S; Fernandes SM; Sun C; Sivina M; Rassenti LZ; Schneider C; Li S; Parida L; Meissner A; Aguet F; Burger JA; Wiestner A; Kipps TJ; Brown JR; Hallek M; Stewart C; Neuberg DS; Martín-Subero JI; Puente XS; Stilgenbauer S; Wu CJ; Campo E; Getz G
Nat Genet; 2022 Nov; 54(11):1664-1674. PubMed ID: 35927489
[TBL] [Abstract][Full Text] [Related]
34. Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia.
Schlosser P; Schiwitza A; Klaus J; Hieke-Schulz S; Szic KSV; Duyster J; Trepel M; Zirlik K; Schumacher M; Claus R
Ann Hematol; 2024 May; 103(5):1613-1622. PubMed ID: 38308707
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia.
Hartman ML; Kilianska ZM
Contemp Oncol (Pozn); 2012; 16(6):474-9. PubMed ID: 23788932
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.
Abruzzo LV; Barron LL; Anderson K; Newman RJ; Wierda WG; O'brien S; Ferrajoli A; Luthra M; Talwalkar S; Luthra R; Jones D; Keating MJ; Coombes KR
J Mol Diagn; 2007 Sep; 9(4):546-55. PubMed ID: 17690214
[TBL] [Abstract][Full Text] [Related]
37. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Kujawski L; Ouillette P; Erba H; Saddler C; Jakubowiak A; Kaminski M; Shedden K; Malek SN
Blood; 2008 Sep; 112(5):1993-2003. PubMed ID: 18436738
[TBL] [Abstract][Full Text] [Related]
38. Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression.
Işıksaçan N; Çınar S; Aktaş Çetin E; Aktan M; Deniz G
Turk J Haematol; 2016 Sep; 33(3):202-8. PubMed ID: 26376785
[TBL] [Abstract][Full Text] [Related]
39. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
40. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
Ronchetti D; Mosca L; Cutrona G; Tuana G; Gentile M; Fabris S; Agnelli L; Ciceri G; Matis S; Massucco C; Colombo M; Reverberi D; Recchia AG; Bossio S; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
BMC Med Genomics; 2013 Sep; 6():27. PubMed ID: 24004562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
